Bio-Rad
JP Morgan Healthcare Conference, Day 3: Invitae, Bio-Rad, Bio-Techne, Opko
On the penultimate day of the conference, Invitae provided color on its recent decisions to pull out of certain businesses, while Bio-Rad talked about its clinical plans.
Top Five Articles on 360Dx Last Week: FDA Clearances; Siemens' Diagnostics Plans; and More
Last week, readers were most interested in the diagnostic tests and platforms that were 510(k) cleared by the FDA last month.
Bio-Rad Laboratories, NuProbe USA Ink Licensing and Development Agreement
NuProbe will exclusively license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays.
360Dx Top 30 Rises 2 Percent After Months of Decline
Of the 30 companies in the index, 22 saw their stock prices rise, while eight firms saw their share prices decrease.
Top Five Articles on 360Dx Last Week: Roche FDA OK for COVID-19 Test; Bio-Rad Q3 Earnings; More
Last week, 360Dx's readers were most interested in Roche obtaining US Food and Drug Administration 510(k) clearance for its COVID-19 PCR test.
Oct 28, 2022
Jul 29, 2022
Feb 11, 2022
Bio-Rad Q4 Revenues Fall 7 Percent
Oct 12, 2021
Apr 29, 2021
Bio-Rad Q1 Revenues Rise 27 Percent, Beat Estimates
Feb 12, 2021